ABSIS与PDAI天疱疮严重程度评分的国际大型验证
在天疱疮新诊断患者中评估ABSIS与PDAI评分者间信度及与其他严重度标志物的相关性。31个中心连续入组116例(寻常型天疱疮84例、落叶型天疱疮32例),基线ABSIS与PDAI的ICC分别为0.90与0.91,随访期间两者ICC均高于0.70。ABSIS与PDAI皮肤亚评分分别与抗DSG1和抗DSG3 ELISA值演变相关,黏膜亚评分未显示相关。
要点
- 基线ABSIS与PDAI的ICC分别为0.90和0.91,评分者间信度良好。
- 随访期间ABSIS与PDAI的ICC均保持高于0.70。
- 皮肤亚评分与抗DSG1/DSG3 ELISA值演变相关,黏膜亚评分未显示相关。
核心结论
- ABSIS与PDAI评分是准确评估天疱疮活动的稳健工具。
研究设计与样本
- 大型国际研究,31个中心连续入组新诊断天疱疮患者,由同一两名盲法研究者于24个月期间记录严重度评分。
- 共纳入116例天疱疮患者,其中寻常型天疱疮84例、落叶型天疱疮32例。
- 每次访视采集血清行ELISA检测抗桥粒芯蛋白抗体,计算组内相关系数(ICC)与Spearman秩相关系数。
主要发现
- 基线ABSIS的ICC为0.90(95%CI=0.85-0.93),PDAI的ICC为0.91(95%CI=0.87-0.94)。
- PDAI在中等与广泛范围天疱疮的ICC分别为0.82(95%CI=0.63-0.92)与0.80(95%CI=0.62-0.90),高于中间(显著)范围患者的ICC=0.50(95%CI=0.27-0.68)。
- ABSIS在中等范围患者的ICC为0.44(95%CI=0.004-0.74),低于中间或广泛范围患者的ICC=0.69(95%CI=0.51-0.81)与ICC=0.75(95%CI=0.51-0.88)。
- 随访期间ABSIS与PDAI的ICC均保持高于0.70。
- ABSIS与PDAI皮肤亚评分分别与抗DSG1和抗DSG3 ELISA值演变相关(r=0.71与r=0.75),黏膜亚评分未显示相关(r=0.32与r=0.37)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Pemphigus Disease Area Index (PDAI) and Autoimmune Bullous Skin Disorder Intensity-Score (ABSIS) scores have been proposed to provide an objective measure of pemphigus activity. These scores have been evaluated only on already treated patients mainly with mild to moderate activity. The objective was to assess the interrater reliability of ABSIS and PDAI scores and their correlation with other severity markers in a large international study. Consecutive patients with newly diagnosed pemphigus were enrolled in 31 centers. Severity scores were recorded during a 24-month period by the same two blinded investigators. Serum was collected at each visit for ELISA measurement of anti-desmoglein antibodies. The intraclass correlation coefficient (ICC) and Spearman rank correlation coefficient were calculated. A total of 116 patients with pemphigus vulgaris (n = 84) or pemphigus foliaceus (n = 32) were included. At baseline, the ABSIS and PDAI ICCs were 0.90 (95% confidence interval [CI] = 0.85-0.93), and 0.91(95% CI = 0.87-0.94), respectively. The ICCs for PDAI were higher in moderate and extensive pemphigus (ICC = 0.82, 95% CI = 0.63-0.92 and ICC = 0.80, 95% CI = 0.62-0.90, respectively) than in patients with intermediate (significant) extent (ICC = 0.50, 95% CI = 0.27-0.68). Conversely, the ICCs for ABSIS were lower in patients with moderate extent (ICC = 0.44, 95% CI = 0.004-0.74) than in those with intermediate or extensive forms, (ICC = 0.69, 95% CI = 0.51-0.81 and ICC = 0.75, 95% CI = 0.51-0.88, respectively). During patients' follow-up, the ICCs of both ABSIS and PDAI scores remained higher than 0.70. ABSIS and PDAI skin (r = 0.71 and r = 0.75) but not mucosal (r = 0.32 and r = 0.37) subscores were correlated with the evolution of anti-DSG1 and anti-DSG3 ELISA values, respectively. ABSIS and PDAI scores are robust tools to accurately assess pemphigus activity.
引用
- Hébert V, Boulard C, Houivet E, et al. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores. J Invest Dermatol. 2018. PMID: 30301637. doi:10.1016/j.jid.2018.04.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。